GoodRx Holdings Inc.

02/26/2026 | Press release | Distributed by Public on 02/26/2026 05:03

Initial Registration Statement for Employee Benefit Plan (Form S-8)

As filed with the Securities and Exchange Commission on February 25, 2026
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under
The Securities Act of 1933
GoodRx Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware
47-5104396
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
2701 Olympic Boulevard
Santa Monica, CA 90404
(855) 268-2822
(Address, including zip code and telephone number, including area code, of Registrant's principal executive offices)
GoodRx Holdings, Inc. 2020 Incentive Award Plan
GoodRx Holdings, Inc. 2020 Employee Stock Purchase Plan
(Full title of the plans)
Christopher McGinnis
Chief Financial Officer
2701 Olympic Boulevard
Santa Monica, CA 90404
(855) 268-2822
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Marc D. Jaffe
Benjamin J. Cohen
Jenna Cooper
Latham & Watkins LLP
1271 Avenue of the Americas
New York, NY 10020
(212) 906-1200
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller
reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller
reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☒
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed with the Securities and Exchange Commission (the
"Commission") for the purpose of registering an additional 31,525,813 shares of Class A common stock, par value $0.0001 per
share (the "Class A Common Stock"), of GoodRx Holdings, Inc. (the "Registrant"), issuable under the following employee
benefit plans for which registration statements of the Registrant on Form S-8 (File No. 333-249069), Form S-8 (File No.
333-254184), Form S-8 (File No. 333-263118), Form S-8 (File No. 333-270149), Form S-8 (File No. 333-277511) and Form S-8
(File No. 333-285349) are effective: (i) the GoodRx Holdings, Inc. 2020 Incentive Award Plan and (ii) the GoodRx Holdings,
Inc. 2020 Employee Stock Purchase Plan.
Pursuant to General Instruction E of Form S-8, the contents of the above-referenced prior registration statements are
incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently
filed document, which is incorporated by reference herein or therein.
Item 8. EXHIBITS.
Incorporated by Reference
Exhibit
Number
Exhibit Description
Form
File
Number
Filing
Date
Exhibit
Filed
Herewith
4.1
8-K
001-39549
9-28-2020
3.1
4.2
8-K
001-39549
9-28-2020
3.2
4.3
S-1/A
333-248465
8-28-2020
4.1
5.1
Opinion of Latham & Watkins LLP
X
23.1
Consent of PricewaterhouseCoopers LLP
X
23.2
Consent of Latham & Watkins LLP
(included in Exhibit 5.1)
X
24.1
Power of Attorney
X
99.1
S-8
333-249069
9-25-2020
99.2
99.1.1
S-1/A
333-248465
9-14-2020
10.3.1
99.1.2
S-1/A
333-248465
9-14-2020
10.3.2
99.1.5
10-Q
001-39549
5-13-2021
10.1
99.1.6
10-K
001-39549
2-29-2024
10.18.1
99.1.7
10-K
001-39549
2-29-2024
10.18.2
99.1.8
10-Q
001-39549
10.1
10.1
99.1.9
10-Q
001-39549
10.2
10.2
99.2
S-1/A
333-248465
9-14-2020
10.4
107.1
Filing Fee Table
X
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to
believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the City of Santa Monica, State of California, on this 25th day of
February, 2026.
GOODRX HOLDINGS, INC.
By:
/s/ Christopher McGinnis
Christopher McGinnis
Chief Financial Officer & Treasurer
SIGNATURES AND POWER OF ATTORNEY
We, the undersigned officers and directors of GoodRx Holdings, Inc., hereby severally constitute and appoint Wendy Barnes and
Christopher McGinnis, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-
fact and agents, with full power of substitution and resubstitution in each of them for him or her and in his or her name, place and
stead, and in any and all capacities, to sign this registration statement and any and all amendments (including post-effective
amendments) to this registration statement and all documents relating thereto, and to file the same, with all exhibits thereto, and
other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be
done in and about the premises, as full to all intents and purposes as he or she might or could do in person, hereby ratifying and
confirming all that said attorneys-in-fact and agents or any of them, or their or his or her substitute or substitutes, may lawfully do
or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the
following persons in the capacities held on the dates indicated.
Signature
Title
Date
/s/ Wendy Barnes
Chief Executive Officer & President
February 25, 2026
Wendy Barnes
(Principal Executive Officer)
/s/ Christopher McGinnis
Chief Financial Officer & Treasurer
February 25, 2026
Christopher McGinnis
(Principal Financial Officer)
/s/ Romin Nabiey
Chief Accounting Officer
February 25, 2026
Romin Nabiey
(Principal Accounting Officer)
/s/ Trevor Bezdek
Co-Chairman of the Board
February 25, 2026
Trevor Bezdek
/s/ Scott Wagner
Co-Chairman of the Board
February 25, 2026
Scott Wagner
/s/ Christopher Adams
Director
February 25, 2026
Christopher Adams
/s/ Ronald E. Bruehlman
Director
February 25, 2026
Ronald E. Bruehlman
/s/ Ian T. Clark
Director
February 25, 2026
Ian T. Clark
/s/ Dipanjan Deb
Director
February 25, 2026
Dipanjan Deb
/s/ Douglas Hirsch
Director
February 25, 2026
Douglas Hirsch
/s/ Kelly J. Kennedy
Director
February 25, 2026
Kelly J. Kennedy
/s/ Gregory Mondre
Director
February 25, 2026
Gregory Mondre
/s/ Agnes Rey-Giraud
Director
February 25, 2026
Agnes Rey-Giraud
GoodRx Holdings Inc. published this content on February 26, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 26, 2026 at 11:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]